Funded Projects › HORIZON
GLUMON · Next generation in-blood glucose monitoring using non-invasive optoacoustic sensing
GLUMON aims to leverage a new class of a biomedical optoacoustic sensor developed under the FETOpen project RSENSE (GA #862811) and offer the next generation of non-invasive biochemical in-vivo sensing. The preliminary sensor for non-invasive in-blood glucose sensing has already produced outstanding findings and places the technology well ahead of its competition. Addressing the limitations of existing sensors, mainly accurate non-invasive continuous monitoring of blood-glucose as well as comfort, the GLUMON sensor will better address diabetes healthcare needs. As a secondary goal and contingency plan, GLUMON will exploit this technology as a lipid sensor and build further potential by addressing the emerging precision nutrition market.The objectives of the GLUMON project are to:1) mature the technology from a lab bench-top setup to a functional portable sensor prototype
Consortium · 6 organisations
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
DE · €852,978
ALIRA HEALTH SL
ES · €150,000
MEDIZINISCHE UNIVERSITAT GRAZ
AT · €320,875
RAYFOS LTD
UK
KLINIKUM DER TECHNISCHEN UNIVERSITÄT MÜNCHEN (TUM KLINIKUM)
DE · €309,625
STHESIS GMBH
DE · €560,732
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.